Foamix Pharma Ord (NASDAQ:FOMX).
Wells Fargo & Company/mn says it raised its investment in Foamix Pharma Ord stock by 36.4% in its quarterly SEC filing. Its investment was valued at $8,000 an increase of $3,000 according to the filing.
Several firms have shifted positions in (FOMX). Menora Mivtachim Holdings Ltd. cut its stake by shedding 9,840 shares a decrease of 33.5% from 06/30/2017 to 09/30/2017. Menora Mivtachim Holdings Ltd. owns 19,500 shares with a value of $108,000. The value of the position overall is down by 20.6%. As of quarter end Bank Of NEW York Mellon Corp had sold 1,215 shares trimming its holdings by 6.0%. The value of the investment in Foamix Pharma Ord increased from $94,000 to $105,000 increasing 11.7% quarter to quarter.
Van Eck Associates Corp added to its ownership by buying 507 shares an increase of 4.7% in the quarter. Van Eck Associates Corp now holds 11,351 shares valued at $63,000. The total value of its holdings increased 26.0%.
HC Wainwright updated guidance on FOMX with a rating of “Buy”.
The company is up from yesterday’s close of 5.56. Foamix Pharma Ord currently has a P/E ratio of N/A and the market cap is 210.00M. As of the last earnings report the EPS was $-1.31 with 37.43M shares currently outstanding.
Traders are more bearish recently if you watch the rise in short interest. The company had a rise in short interest of 10.42% as of October 13, 2017 from the last reporting period. Short interest increased from 1,871,097 to 2,066,065 over that period. The short-interest ratio decreased to 17.0 and the percentage of shorted shares is 0.06% as of October 13.